Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs.
Ying Hong LiXiao Xu LiJiajun HongYunxia WangJianbo FuHong YangChun Yan YuFeng Cheng LiJie HuWeiwei XueYu Yang JiangYu Zong ChenFeng ZhuPublished in: Briefings Bioinform. (2020)